UBS Group AG - VIRPAX PHARMACEUTICALS INC ownership

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 19 filers reported holding VIRPAX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$94
-98.7%
118
-99.0%
0.00%
Q4 2022$7,346
+4.9%
11,849
+88.2%
0.00%
Q3 2022$7,000
-82.1%
6,296
-44.7%
0.00%
Q4 2021$39,000
+116.7%
11,385
+188.8%
0.00%
Q2 2021$18,000
+28.6%
3,942
+32.3%
0.00%
Q1 2021$14,0002,9800.00%
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 876,834$3,008,0000.44%
Kepos Capital LP 750,000$2,573,0000.22%
Quantum Private Wealth, LLC 22,500$77,0000.03%
XTX Topco Ltd 10,537$36,0000.02%
Virtu Financial LLC 15,279$52,0000.01%
Engineers Gate Manager LP 11,790$40,0000.00%
OSAIC HOLDINGS, INC. 50$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 25,125$86,0000.00%
WELLS FARGO & COMPANY/MN 52$00.00%
NORTHERN TRUST CORP 15,221$52,0000.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders